Literature DB >> 28351780

Cordycepin negatively modulates lipopolysaccharide-induced cytokine production by up-regulation of heme oxygenase-1.

Rui Qing1, Zezhi Huang1, Yufei Tang1, Qingke Xiang1, Fan Yang2.   

Abstract

AIMS: The present study is to investigate the effect of cordycepin on the expression of heme oxygenase-1 (HO-1) in lipopolysaccharide (LPS)-activated microphages, as well as its mechanism of action.
METHODS: Mouse RAW264.7 cells were treated with different concentrations of cordycepin for 0-16h. Western blotting was used to determine the expression of HO-1 and the phosphorylation of c-Src and the p47phox subunit of NADPH oxidase. Intracellular reactive oxygen species (ROS) level was determined using H2DCFDA as fluorescent probe. Laser-scanning confocal microscopy was used to visualize the nuclear translocation of NF-E2-related factor 2 (Nrf2). Enzyme-linked immunosorbent assay was performed to measure the inhibitory effect of cordycepin on LPS-induced secretion of tumor necrosis factor-α and interleukin-6.
RESULTS: Cordycepin induced the phosphorylation of c-Src and p47phox subunit of NADPH oxidase in RAW264.7 cells. Cordycepin increased the secretion of ROS by activating NADPH oxidase. In addition, cordycepin enhanced the expression of HO-1 in RAW264.7 cells in both dose- and time-dependent manners. Of note, elevated HO-1 expression induced by cordycepin treatment was regulated by c-Src/NADPH oxidase/ROS pathway. HO-1 expression induced by cordycepin was dependent on the activation of Nrf2, which was regulated by c-Src/NADPH oxidase/ROS. Cordycepin reduced LPS-induced secretion of proinflammatory cytokines through up-regulation of HO-1.
CONCLUSION: The present study demonstrates that cordycepin induces the expression of HO-1 in RAW264.7 cells via c-Src/NADPH oxidase/ROS/Nrf2 pathway, and plays an anti-inflammatory role by inhibiting the secretion of cytokines from macrophages.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cordycepin; Heme oxygenase-1; Macrophages

Mesh:

Substances:

Year:  2017        PMID: 28351780     DOI: 10.1016/j.intimp.2017.03.002

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  Prebiotic supplementation modulates advanced glycation end-products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized-controlled clinical trial.

Authors:  Mahdieh Abbasalizad Farhangi; Parvin Dehghan; Nazli Namazi
Journal:  Eur J Nutr       Date:  2019-11-14       Impact factor: 5.614

2.  Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway.

Authors:  Hui-Bo Wang; Ming-Xia Duan; Man Xu; Si-Hui Huang; Jun Yang; Jian Yang; Li-Bo Liu; Rong Huang; Chun-Xia Wan; Zhen-Guo Ma; Qing-Qing Wu; Qi-Zhu Tang
Journal:  J Cell Mol Med       Date:  2019-06-21       Impact factor: 5.310

Review 3.  Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.

Authors:  Chang Hoon Lee
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

Review 4.  A Systematic Review of the Biological Effects of Cordycepin.

Authors:  Masar Radhi; Sadaf Ashraf; Steven Lawrence; Asta Arendt Tranholm; Peter Arthur David Wellham; Abdul Hafeez; Ammar Sabah Khamis; Robert Thomas; Daniel McWilliams; Cornelia Huiberdina de Moor
Journal:  Molecules       Date:  2021-09-28       Impact factor: 4.411

5.  Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway.

Authors:  Tian Lan; Yang Yu; Jing Zhang; Haonan Li; Qiqing Weng; Shuo Jiang; Song Tian; Tonghao Xu; Sha Hu; Guizhi Yang; Yan Zhang; Weixuan Wang; Lexun Wang; Qing Zhu; Xianglu Rong; Jiao Guo
Journal:  Hepatology       Date:  2021-08       Impact factor: 17.425

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.